OpenAI’s rise isn’t just a business story — it’s an ideological one. On Equity, Karen Hao, author of Empire AI, explores how the cult of AGI has fueled a billion-dollar race, justified massive ...

This achievement not only graced the cover of Nature, but its core contributors also received the Nobel Prize, with global researchers downloading the predicted results over 200 million times through ...

Today, Pushmeet Kohli, the head of science at Google DeepMind, reveals for the first time the internal principles behind this method: they focus solely on three types of problems—those that are ...

Artificial intelligence could reduce drug discovery from years to months, according to Demis Hassabis, CEO of Isomorphic Labs ...

Demis Hassabis, the head of Google's DeepMind, believes AI will soon revolutionise medicine, accelerating the drug discovery ...

Discovering new medicines takes years and is marred by an astronomical failure rate. The Nobel Prize-winning head of Alphabet ...

Isomorphic Labs has raised $600 million and is targeting cancer and immune disorders, with executives saying AI-designed ...

AlphaFold 3 predicts proteins and DNA interactions, promising faster drug discovery and better treatments for patients ...

Unlike quantum computing, which faces steep hardware challenges, AI research can be iterated, trained, and scaled on existing infrastructure. In practical terms, this means AI might pose a practical ...

Scientific sleuths hunt for these hallucinations or " digital fossils " to help uncover fraudulent AI written papers and have ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Cambridge’s two universities and three NHS trusts have joined forces to find new industry partners to help them invent, test ...